498 results on '"Thamm, Douglas H."'
Search Results
2. VDX-111 targets proliferative pathways in canine cancer cell lines
3. Alternating rabacfosadine and doxorubicin for treatment of naïve canine lymphoma
4. Early progression during or after cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy indicates poor outcome with rescue protocols in dogs with multicentric lymphoma.
5. Prospective clinical trial testing COXEN-based gene expression models of chemosensitivity in dogs with spontaneous osteosarcoma
6. Editorial
7. Canine Non-Angiogenic, Non-Myogenic Splenic Stromal Sarcoma: a Retrospective Clinicopathological Analysis and Investigation of Podoplanin as a Marker of Tumour Histogenesis
8. Parthenolide As a Therapeutic for Disseminated Canine Neoplasms
9. Review: The PI3K-AKT-mTOR signal transduction pathway in canine cancer.
10. Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma
11. Design of a randomized, placebo-controlled study evaluating efficacy and safety of a cancer preventative vaccine in dogs
12. Review: The PI3K-AKT-mTOR signal transduction pathway in canine cancer
13. Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma
14. Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma
15. Immunohistochemical evidence of NF-kB activation in canine lymphomas, histiocytic sarcomas, hemangiosarcomas, and mast cell tumors.
16. Tumors of the Respiratory System
17. Cancer of the Gastrointestinal Tract
18. Contributors
19. Supportive Care for the Cancer Patient
20. The Etiology of Cancer
21. Design of a randomized, placebo-controlled study evaluating efficacy and safety of a cancer preventative vaccine in dogs
22. Tumor-associated macrophages: Prognostic and therapeutic targets for cancer in humans and dogs
23. Abstract 6233: Omacetaxine reduces c-MYC expression and demonstrates antitumor effects in osteosarcoma
24. Abstract 4465: Evaluation of tumor draining lymph nodes in dogs with spontaneously arising osteosarcoma using single-cell sequencing
25. Supplementary Figure from Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma
26. Supplementary Data from Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma
27. Supplementary Table from Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma
28. Supplementary Tables 1-2, Figures 1-3, Methods from Expression and Function of Survivin in Canine Osteosarcoma
29. Data from Expression and Function of Survivin in Canine Osteosarcoma
30. Phase-I trial of survivin inhibition with EZN-3042 in dogs with spontaneous lymphoma
31. Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy
32. Mast Cell Tumors
33. Clinical Trials and Developmental Therapeutics
34. Molecular/Targeted Therapy of Cancer
35. Miscellaneous Tumors
36. Hematopoietic Tumors
37. Configuration of pathologic fractures in dogs with osteosarcoma following stereotactic body radiation therapy: A retrospective analysis
38. sj-pdf-1-vet-10.1177_03009858231180484 – Supplemental material for Immunohistochemical evidence of NF-kB activation in canine lymphomas, histiocytic sarcomas, hemangiosarcomas, and mast cell tumors
39. Ivermectin inhibits canine mammary tumor growth by regulating cell cycle progression and WNT signaling
40. A temporary indwelling intravascular aphaeretic system for in vivo enrichment of circulating tumor cells
41. Veterinary oncology clinical trials: Design and implementation
42. Spontaneous Companion Animal (Pet) Cancers
43. In vitro antineoplastic effects of auranofin in canine lymphoma cells
44. Retrospective Evaluation of Outcome in Dogs With Appendicular Osteosarcoma Following Hypofractionated Palliative Radiation Therapy With or Without Bisphosphonates: 165 Cases (2010–2019)
45. Review: NF-kB activation in canine cancer
46. Spontaneously Occurring Tumors in Companion Animals as Models for Drug Development
47. Comparative pharmacokinetic properties and antitumor activity of the marine HDACi Largazole and Largazole peptide isostere
48. Use of computed tomography and nuclear scintigraphy for diagnosis and staging of primary anterior uveal osteosarcoma in a rabbit (Oryctolagus cuniculus)
49. Multicenter, randomized, double‐blinded, placebo‐controlled study of rabacfosadine in dogs with lymphoma
50. Effects of morphine on histamine release from two cell lines of canine mast cell tumor and on plasma histamine concentrations in dogs with cutaneous mast cell tumor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.